PDCD1 and neoplasm: Binding to PD-L1 ligand, PD-1 inhibits intracellular signaling in effector T cells and Treg cells, mediates T cell apoptosis, or induces T cell dysfunctional states, which decrease tumor immunity and promote tumor survival (Keir et al., 2008; Wei et al., 2017).